CCL21 and neoplasm: In poor immunogenic CT26 tumor models, another engineered bacteria (SLC:GM-CSF) expressing granulocyte-macrophage colony-stimulating factor (GM-CSF) were applied to enhance the antitumor effect of SLC:PD-L1nb and SLC:CTLA-4nb.